In-Hospital Outcomes after Endovascular Therapy for Acute Limb Ischemia: A Report from a Japanese Nationwide Registry [J-EVT Registry].


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Nov 2021
Historique:
pubmed: 25 11 2020
medline: 5 2 2022
entrez: 24 11 2020
Statut: ppublish

Résumé

The aim of the current study was to describe the clinical profile, frequency of in-hospital complications, and predictors of adverse events in patients undergoing endovascular therapy (EVT) for acute limb ischemia (ALI), and to compare them with those of patients undergoing EVT for chronic symptomatic peripheral artery disease (PAD). The current study compared 2,398 cases of EVT for ALI with 74,171 cases of EVT for chronic symptomatic PAD performed between January 2015 and December 2018 in Japan. We first compared the clinical profiles of ALI patients with those of PAD patients. We then evaluated the proportion of in-hospital complications and investigated their risk factors in the ALI patients. The association of clinical characteristics with the risk of in-hospital complications was analyzed via logistic regression modeling. Patients with ALI were older and had a higher prevalence of female sex, impaired mobility, and history of cerebrovascular disease, but a lower prevalence of cardiovascular risk factors and history of coronary artery disease. The proportion of in-hospital EVT-related complications in ALI was 6.1% and was significantly higher compared with those in chronic symptomatic PAD patients (2.0%, P<0.001). Bedridden status (adjusted odds ratio [aOR], 1.74 [1.14 to 2.66]; P=0.010), history of coronary artery disease (aOR, 1.80 [1.21 to 2.68]; P=0.004), and a suprapopliteal lesion (aOR, 1.70 [1.05 to 2.74]; P=0.030) were identified as independent risk factors for in-hospital complications. The current study demonstrated that ALI patients with significant comorbidities show a higher proportion of in-hospital complications after EVT.

Identifiants

pubmed: 33229856
doi: 10.5551/jat.60053
pmc: PMC8592702
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1145-1152

Références

Diabetol Int. 2018 Mar 27;9(1):1-45
pubmed: 30603347
Clin Radiol. 2008 Jun;63(6):636-41
pubmed: 18455554
Eur Heart J. 2018 Mar 1;39(9):763-816
pubmed: 28886620
J Vasc Surg. 2014 Sep;60(3):669-77.e2
pubmed: 24768362
J Vasc Surg. 2017 Jun;65(6):1706-1712
pubmed: 28216361
J Am Coll Cardiol. 2017 Mar 21;69(11):1465-1508
pubmed: 27851991
Br J Surg. 2014 Aug;101(9):1105-12
pubmed: 24965149
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67
pubmed: 17223489
Vasc Med. 2016 Oct;21(5):453-458
pubmed: 26994007
J Endovasc Ther. 2003 Feb;10(1):81-5
pubmed: 12751936
J Vasc Surg. 2013 Sep;58(3):673-81.e1
pubmed: 23642926
N Engl J Med. 2012 Jun 7;366(23):2198-206
pubmed: 22670905
Int Angiol. 2008 Aug;27(4):313-8
pubmed: 18677294
J Vasc Surg. 2011 Feb;53(2):340-6
pubmed: 21050699
J Vasc Surg. 2019 Mar;69(3):843-849
pubmed: 30679009
Australas Med J. 2014 Dec 31;7(12):471-5
pubmed: 25646123
Hypertens Res. 2014 Apr;37(4):253-390
pubmed: 24705419
Ann Vasc Surg. 2016 Feb;31:134-42
pubmed: 26627323
J Vasc Surg. 2015 Jan;61(1):147-54
pubmed: 25080883
Eur J Vasc Endovasc Surg. 2012 Mar;43(3):313-21
pubmed: 22240338
Circulation. 2006 Oct 31;114(18):1914-22
pubmed: 17060384
J Vasc Surg. 2015 Mar;61(3 Suppl):2S-41S
pubmed: 25638515
JAMA. 2012 Oct 24;308(16):1660-7
pubmed: 23093164
Int J Surg. 2011;9(8):632-5
pubmed: 21875696
Medicine (Baltimore). 2015 Jul;94(28):e1164
pubmed: 26181560
J Vasc Surg. 2012 Mar;55(3):721-9
pubmed: 22277685
J Atheroscler Thromb. 2013;20(6):517-23
pubmed: 23665881
Eur J Vasc Endovasc Surg. 2013 Jul;46(1):118-23
pubmed: 23683391
JAMA. 2006 Jan 11;295(2):180-9
pubmed: 16403930

Auteurs

Takuya Tsujimura (T)

Cardiovascular Center, Kansai Rosai Hospital.

Mitsuyoshi Takahara (M)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine.
Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine.

Osamu Iida (O)

Cardiovascular Center, Kansai Rosai Hospital.

Shun Kohsaka (S)

Department of Cardiology, Keio University School of Medicine.

Yoshimitsu Soga (Y)

Department of Cardiology, Kokura Memorial Hospital.

Masahiko Fujihara (M)

Department of Cardiology, Kishiwada Tokushukai Hospital.

Toshiaki Mano (T)

Cardiovascular Center, Kansai Rosai Hospital.

Masanobu Ohya (M)

Department of Cardiology, Kurashiki Central Hospital.

Toshiro Shinke (T)

Department of Cardiology, Showa University School of Medicine.

Tetsuya Amano (T)

Department of Cardiology, Aichi medical University.

Yuji Ikari (Y)

Division of Cardiovascular Medicine, Tokai University Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH